HIV vaccine research

The way forward

Anthony S. Fauci, Margaret I. Johnston, Carl W. Dieffenbach, Dennis R. Burton, Scott M. Hammer, James A. Hoxie, Malcolm Martin, Julie Overbaugh, David Watkins, Adel Mahmoud, Warner C. Greene

Research output: Contribution to journalArticle

202 Citations (Scopus)

Abstract

The need to broaden research directed at answering fundamental questions in HIV vaccine discovery through laboratory, nonhuman primate (NHP), and clinical research has recently been emphasized. In addition, the importance of attracting and retaining young researchers, developing better NHP models, and more closely linking NHP and clinical research is being stressed. In an era of a level budget for biomedical research at the U.S. National Institutes of Health (NIH), HIV/AIDS vaccine research efforts will need to be carefully prioritized such that resources to energize HIV vaccine discovery can be identified. This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities.

Original languageEnglish
Pages (from-to)530-532
Number of pages3
JournalScience
Volume321
Issue number5888
DOIs
StatePublished - Jul 25 2008
Externally publishedYes

Fingerprint

AIDS Vaccines
Primates
Research
National Institute of Allergy and Infectious Diseases (U.S.)
National Institutes of Health (U.S.)
Budgets
Biomedical Research
Research Personnel

ASJC Scopus subject areas

  • General

Cite this

Fauci, A. S., Johnston, M. I., Dieffenbach, C. W., Burton, D. R., Hammer, S. M., Hoxie, J. A., ... Greene, W. C. (2008). HIV vaccine research: The way forward. Science, 321(5888), 530-532. https://doi.org/10.1126/science.1161000

HIV vaccine research : The way forward. / Fauci, Anthony S.; Johnston, Margaret I.; Dieffenbach, Carl W.; Burton, Dennis R.; Hammer, Scott M.; Hoxie, James A.; Martin, Malcolm; Overbaugh, Julie; Watkins, David; Mahmoud, Adel; Greene, Warner C.

In: Science, Vol. 321, No. 5888, 25.07.2008, p. 530-532.

Research output: Contribution to journalArticle

Fauci, AS, Johnston, MI, Dieffenbach, CW, Burton, DR, Hammer, SM, Hoxie, JA, Martin, M, Overbaugh, J, Watkins, D, Mahmoud, A & Greene, WC 2008, 'HIV vaccine research: The way forward', Science, vol. 321, no. 5888, pp. 530-532. https://doi.org/10.1126/science.1161000
Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA et al. HIV vaccine research: The way forward. Science. 2008 Jul 25;321(5888):530-532. https://doi.org/10.1126/science.1161000
Fauci, Anthony S. ; Johnston, Margaret I. ; Dieffenbach, Carl W. ; Burton, Dennis R. ; Hammer, Scott M. ; Hoxie, James A. ; Martin, Malcolm ; Overbaugh, Julie ; Watkins, David ; Mahmoud, Adel ; Greene, Warner C. / HIV vaccine research : The way forward. In: Science. 2008 ; Vol. 321, No. 5888. pp. 530-532.
@article{462f5b96976d49bb9a5cb6ba4831bfec,
title = "HIV vaccine research: The way forward",
abstract = "The need to broaden research directed at answering fundamental questions in HIV vaccine discovery through laboratory, nonhuman primate (NHP), and clinical research has recently been emphasized. In addition, the importance of attracting and retaining young researchers, developing better NHP models, and more closely linking NHP and clinical research is being stressed. In an era of a level budget for biomedical research at the U.S. National Institutes of Health (NIH), HIV/AIDS vaccine research efforts will need to be carefully prioritized such that resources to energize HIV vaccine discovery can be identified. This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities.",
author = "Fauci, {Anthony S.} and Johnston, {Margaret I.} and Dieffenbach, {Carl W.} and Burton, {Dennis R.} and Hammer, {Scott M.} and Hoxie, {James A.} and Malcolm Martin and Julie Overbaugh and David Watkins and Adel Mahmoud and Greene, {Warner C.}",
year = "2008",
month = "7",
day = "25",
doi = "10.1126/science.1161000",
language = "English",
volume = "321",
pages = "530--532",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5888",

}

TY - JOUR

T1 - HIV vaccine research

T2 - The way forward

AU - Fauci, Anthony S.

AU - Johnston, Margaret I.

AU - Dieffenbach, Carl W.

AU - Burton, Dennis R.

AU - Hammer, Scott M.

AU - Hoxie, James A.

AU - Martin, Malcolm

AU - Overbaugh, Julie

AU - Watkins, David

AU - Mahmoud, Adel

AU - Greene, Warner C.

PY - 2008/7/25

Y1 - 2008/7/25

N2 - The need to broaden research directed at answering fundamental questions in HIV vaccine discovery through laboratory, nonhuman primate (NHP), and clinical research has recently been emphasized. In addition, the importance of attracting and retaining young researchers, developing better NHP models, and more closely linking NHP and clinical research is being stressed. In an era of a level budget for biomedical research at the U.S. National Institutes of Health (NIH), HIV/AIDS vaccine research efforts will need to be carefully prioritized such that resources to energize HIV vaccine discovery can be identified. This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities.

AB - The need to broaden research directed at answering fundamental questions in HIV vaccine discovery through laboratory, nonhuman primate (NHP), and clinical research has recently been emphasized. In addition, the importance of attracting and retaining young researchers, developing better NHP models, and more closely linking NHP and clinical research is being stressed. In an era of a level budget for biomedical research at the U.S. National Institutes of Health (NIH), HIV/AIDS vaccine research efforts will need to be carefully prioritized such that resources to energize HIV vaccine discovery can be identified. This article summarizes progress and challenges in HIV vaccine research, the priorities arising from a recent summit at NIAID, and the actions needed, some already under way, to address those priorities.

UR - http://www.scopus.com/inward/record.url?scp=48249134364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249134364&partnerID=8YFLogxK

U2 - 10.1126/science.1161000

DO - 10.1126/science.1161000

M3 - Article

VL - 321

SP - 530

EP - 532

JO - Science

JF - Science

SN - 0036-8075

IS - 5888

ER -